Blavatnik Biomedical Overview
- Investor Type
Blavatnik Biomedical General Information
Blavatnik Biomedical is an accelerator that bridges the gap between innovative, early-stage life science research and successful development of high-impact biomedical products. The firm's integrated approach combines essential funding with development and business expertise, leading to commercial partnerships that bring forth new biomedical discoveries that create value and benefit society.
Actively Seeking New Investments
Primary Investor Type
- 1350 Massachusetts Avenue
- Cambridge, MA 02138
- United States
+1 (617) 000-0000
Blavatnik Biomedical Investments (2)
|Company Name||Deal Date||Deal Type||Deal Size||Industry||Company Stage||Lead Partner|
|StemCellerant||08-Jun-2017||Accelerator/Incubator||Other Pharmaceuticals and Biotechnology||Generating Revenue|
|000000 00000000000||000000000000||Drug Discovery||Generating Revenue|
Want detailed data on 3M+ companies?
What you see here scratches the surfaceRequest a free trial
Want to dig into this profile?
We’ll help you find what you needLearn more
Blavatnik Biomedical Exits (1)
|Company Name||Exit Date||Exit Type||Exit Size|